Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GCSHP2, or glycine cleavage system protein H (aminomethyl carrier) pseudogene 2, is a genomic sequence annotated as a **pseudogene** derived from the parent GCSH gene, which encodes a protein involved in mitochondrial glycine degradation[5][7][8]. As a pseudogene, GCSHP2 is regarded as a **non-coding, nonfunctional relic** that does not produce a functional protein product but may play regulatory roles at the RNA level, such as affecting transcription, regulatory RNA interactions, or gene expression of its parent or related genes[5][8]. It is not considered a therapeutic target (enzyme, receptor, transporter, etc.) and does not have established interacting drugs, biomarker utility, nor clear associations with disease roles or safety concerns[5][8][7]. GCSHP2 is sometimes referred to by alternative names such as GCSH pseudogene 2 and glycine cleavage system protein H pseudogene 2, and is classified under "pseudogene" or "other" molecular categories.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine cleavage system protein H (aminomethyl carrier) pseudogene 2 (GCSHP2).